biotechnology and bioengineering

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Arnaud Rousseau, a sixth-generation farmer in France, in a field of rapeseed. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were
Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Arnaud Rousseau, a sixth-generation farmer in France, in a field of rapeseed. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were
Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Arnaud Rousseau, a sixth-generation farmer in France, in a field of rapeseed. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were
Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Arnaud Rousseau, a sixth-generation farmer in France, in a field of rapeseed. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were
Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Uncertain Harvest: Doubts About the Promised Bounty of Genetically Modified Crops

Arnaud Rousseau, a sixth-generation farmer in France, in a field of rapeseed. Twenty years ago, Europe largely rejected genetic modification at the same time the United States and Canada were
James Simons’s Foundation Starts New Institute for Computing, Big Data

James Simons’s Foundation Starts New Institute for Computing, Big Data

Part of the work at the Flatiron Institute involves complicated numerical simulations of exploding stars, as shown here.
James Simons’s Foundation Starts New Institute for Computing, Big Data

James Simons’s Foundation Starts New Institute for Computing, Big Data

Part of the work at the Flatiron Institute involves complicated numerical simulations of exploding stars, as shown here.
James Simons’s Foundation Starts New Institute for Computing, Big Data

James Simons’s Foundation Starts New Institute for Computing, Big Data

Part of the work at the Flatiron Institute involves complicated numerical simulations of exploding stars, as shown here.
Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump

Wary Drug Makers Move to Fend Off Further Attacks Under Donald Trump

Novo Nordisk’s insulin production plant in Chartres, France.
Clean Tech Rises Again, Retooling Nature for Industrial Use

Clean Tech Rises Again, Retooling Nature for Industrial Use

A crystallized version of malonic acid, made by yeast, at Lygos, a clean tech start-up in Berkeley, Calif. The acid is traditionally derived from cyanide for use in cosmetics.
Clean Tech Rises Again, Retooling Nature for Industrial Use

Clean Tech Rises Again, Retooling Nature for Industrial Use

A crystallized version of malonic acid, made by yeast, at Lygos, a clean tech start-up in Berkeley, Calif. The acid is traditionally derived from cyanide for use in cosmetics.
Clean Tech Rises Again, Retooling Nature for Industrial Use

Clean Tech Rises Again, Retooling Nature for Industrial Use

A crystallized version of malonic acid, made by yeast, at Lygos, a clean tech start-up in Berkeley, Calif. The acid is traditionally derived from cyanide for use in cosmetics.

National Biotechnology Panel Faces New Conflict of Interest Questions

A committee is under fire for how its members were selected. Several have financial ties to biotech businesses, potentially giving short shrift to health and environmental worries.

National Biotechnology Panel Faces New Conflict of Interest Questions

A committee is under fire for how its members were selected. Several have financial ties to biotech businesses, potentially giving short shrift to health and environmental worries.

National Biotechnology Panel Faces New Conflict of Interest Questions

A committee is under fire for how its members were selected. Several have financial ties to biotech businesses, potentially giving short shrift to health and environmental worries.

National Biotechnology Panel Faces New Conflict of Interest Questions

A committee is under fire for how its members were selected. Several have financial ties to biotech businesses, potentially giving short shrift to health and environmental worries.
Monsanto Emails Raise Issue of Influencing Research on Roundup Weed Killer

Monsanto Emails Raise Issue of Influencing Research on Roundup Weed Killer

The weed killer Roundup, Monsanto’s highest-profile product. Documents revealed internal debate at the company over Roundup’s safety.
What Does It Cost to Create a Cancer Drug? Less Than You’d Think

What Does It Cost to Create a Cancer Drug? Less Than You’d Think

A researcher at Pharmacyclics in Sunnyvale, Calif., which developed the cancer drug ibrutinib. The drug was sold for $21 billion.